Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting.

by Benjamin Maasoumy, Kerstin Port, Antoaneta Angelova Markova, Beatriz Calle Serrano, Magdalena Rogalska-Taranta, Lisa Sollik, Carola Mix, Janina Kirschner, Michael P Manns, Heiner Wedemeyer, Markus Cornberg
Published 2013-01-01

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.

by Steffen B Wiegand, Benjamin Heidrich, Simone Susser, Magdalena Rogalska-Taranta, Jörg Petersen, Klaus H W Böker, Natalia Grigorian, Ralph Link, Uwe Naumann, Christine John, Stefan Lueth, Peter Malfertheiner, Michael P Manns, Heiner Wedemeyer, Christoph Sarrazin, Markus Cornberg
Published 2015-01-01